市场调查报告书
商品编码
1446236
2024-2028年家庭输液治疗的全球市场Global Home Infusion Therapy Market 2024-2028 |
2023-2028年家庭输液治疗市场预估为173.7亿美元,预测期内复合年增率为8.12%。
该报告包括对家庭输液治疗市场的总体分析、市场规模/预测、趋势、成长动力、挑战以及涵盖约 25 家供应商的供应商分析。
它提供了对当前市场状况、最新趋势和驱动因素以及整体市场环境的最新分析。该市场的推动因素包括输液帮浦和远端监控设备的技术进步、慢性病盛行率的增加以及全球老年人口需要长期医疗照护的成长。
市场范围 | |
---|---|
基准年 | 2024年 |
结束年份 | 2028年 |
预测期 | 2024-2028 |
成长动力 | 加速度 |
2024年与前一年同期比较 | 7.58% |
复合年增长率 | 8.12% |
增量 | 173.7亿美元 |
研究指出,患者照护和治疗选择方面的发展和合作的增加是推动未来几年家庭输液治疗市场成长的关键因素之一。此外,对专业药房服务与家庭输液治疗提供的服务相结合的需求不断增长,以及家庭输液专业医疗保健专业人员数量的增加也将导致巨大的市场需求。
The home infusion therapy market is forecasted to grow by USD 17.37 bn during 2023-2028, accelerating at a CAGR of 8.12% during the forecast period. The report on the home infusion therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advancements in infusion pumps and remote monitoring devices, increasing prevalence of chronic diseases, and growing geriatric population worldwide requiring long-term medical care.
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 7.58% |
CAGR | 8.12% |
Incremental Value | $17.37bn |
Technavio's home infusion therapy market is segmented as below:
By Application
By Product
By Geographical Landscape
This study identifies the increasing developments and collaborations for patient care and therapeutic options as one of the prime reasons driving the home infusion therapy market growth during the next few years. Also, expanding demand for specialty pharmacy services integrated with home infusion therapy offerings and rising initiations on specialized healthcare professionals for home infusion will lead to sizable demand in the market.
The report on the home infusion therapy market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading home infusion therapy market vendors that include B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Bio-Med Pvt. Ltd., Cardinal Health Inc., Catholic Health Initiatives, Community Surgical Supply, Fresenius SE and Co. KGaA, Health Vista Pvt Ltd., Health2home, ICU Medical Inc., Medix Infusion, Nipro Corp., Option Care Health Inc., Prochant, Reviv Genetics Ltd., Sober Care Surgical, UnitedHealth Group Inc., University of Pennsylvania Health System, and Walgreens Boots Alliance Inc.. Also, the home infusion therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: